MX2013003245A - Vacuna contra virus de diarrea viral de bovinos. - Google Patents
Vacuna contra virus de diarrea viral de bovinos.Info
- Publication number
- MX2013003245A MX2013003245A MX2013003245A MX2013003245A MX2013003245A MX 2013003245 A MX2013003245 A MX 2013003245A MX 2013003245 A MX2013003245 A MX 2013003245A MX 2013003245 A MX2013003245 A MX 2013003245A MX 2013003245 A MX2013003245 A MX 2013003245A
- Authority
- MX
- Mexico
- Prior art keywords
- vaccines
- bvdv vaccine
- virus
- bvdv
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
- C12N2770/24362—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a virus de BVD y a sus usos, a vacunas y vacunas de combinación que comprenden dicho virus, su uso como un medicamento, su uso en el tratamiento de diarrea viral de bovino y a métodos para la preparación de dichas vacunas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38501010P | 2010-09-21 | 2010-09-21 | |
EP10177931 | 2010-09-21 | ||
PCT/EP2011/066377 WO2012038454A1 (en) | 2010-09-21 | 2011-09-21 | Bvdv vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013003245A true MX2013003245A (es) | 2013-05-22 |
MX347911B MX347911B (es) | 2017-05-17 |
Family
ID=43110616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013003245A MX347911B (es) | 2010-09-21 | 2011-09-21 | Vacuna contra virus de diarrea viral de bovinos. |
Country Status (11)
Country | Link |
---|---|
US (1) | US9878030B2 (es) |
EP (1) | EP2618841B1 (es) |
CN (1) | CN103338785B (es) |
AU (1) | AU2011306957C1 (es) |
BR (1) | BR112013006515B1 (es) |
CA (1) | CA2811243C (es) |
ES (1) | ES2606605T3 (es) |
MX (1) | MX347911B (es) |
RU (1) | RU2578943C2 (es) |
WO (1) | WO2012038454A1 (es) |
ZA (1) | ZA201301950B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2606605T3 (es) | 2010-09-21 | 2017-03-24 | Intervet International B.V. | Vacuna para el BVDV |
WO2014043215A1 (en) * | 2012-09-11 | 2014-03-20 | The Texas A&M University System | Bi-specifc diabodies for masking and targeting vaccines |
CN105949286A (zh) * | 2016-07-04 | 2016-09-21 | 中国兽医药品监察所 | 牛病毒性腹泻病毒i型e2蛋白的表达及应用 |
CN108456663B (zh) * | 2018-03-26 | 2021-09-21 | 中国农业科学院兰州兽医研究所 | 一种1型牛病毒性腹泻病毒样颗粒及其制备与应用 |
CN108614121B (zh) * | 2018-05-04 | 2020-11-20 | 山东师范大学 | 牛病毒性腹泻病毒e2蛋白抗原多表位融合肽及其制备与应用 |
CN111533813B (zh) * | 2020-07-09 | 2020-10-16 | 苏州世诺生物技术有限公司 | 牛病毒性腹泻病毒重组亚单位疫苗 |
CN113403256B (zh) * | 2021-06-16 | 2023-04-18 | 中国农业科学院特产研究所 | 一种稳定产生牛病毒性腹泻病毒抗原的细胞系及抗体胶体金检测试纸条的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001613A (en) | 1996-05-24 | 1999-12-14 | Board Of Regents Of University Of Nebraska | Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid |
EP0965639A1 (en) | 1998-06-05 | 1999-12-22 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
US6168942B1 (en) | 1998-11-10 | 2001-01-02 | Pfizer Inc. | Attenuated forms of bovine viral diarrhea virus |
EP1104676A1 (en) | 1999-11-30 | 2001-06-06 | Boehringer Ingelheim Vetmedica Gmbh | Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
CA2363493C (en) | 2000-11-22 | 2006-06-06 | Xuemei Cao | Attenuated forms of bovine viral diarrhea virus |
US6974575B2 (en) * | 2001-08-28 | 2005-12-13 | Pfizer Inc. | Generation of type I/type II hybrid form of bovine viral diarrhea virus for use as vaccine |
DE10143813A1 (de) | 2001-09-06 | 2003-04-10 | Boehringer Ingelheim Vetmed | Infektiöser Rindervirusdiarrhoe-Virusklon |
SI1727562T1 (sl) * | 2004-03-17 | 2008-10-31 | Pharmacia & Upjohn Co Llc | Postopek cepljenja proti testikularni okuĹľbi z BVDV |
DE102004025452A1 (de) * | 2004-05-19 | 2006-01-19 | Boehringer Ingelheim Vetmedica Gmbh | Vakzine enthaltend BVDV |
US20090068223A1 (en) | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
WO2010064164A1 (en) * | 2008-12-03 | 2010-06-10 | Pfizer Inc. | Bovine viral diarrhea virus with a modified erns protein |
ES2606605T3 (es) | 2010-09-21 | 2017-03-24 | Intervet International B.V. | Vacuna para el BVDV |
-
2011
- 2011-09-21 ES ES11760764.8T patent/ES2606605T3/es active Active
- 2011-09-21 CN CN201180055945.8A patent/CN103338785B/zh not_active Expired - Fee Related
- 2011-09-21 EP EP11760764.8A patent/EP2618841B1/en active Active
- 2011-09-21 RU RU2013118351/15A patent/RU2578943C2/ru active
- 2011-09-21 US US13/825,050 patent/US9878030B2/en active Active
- 2011-09-21 AU AU2011306957A patent/AU2011306957C1/en not_active Ceased
- 2011-09-21 MX MX2013003245A patent/MX347911B/es active IP Right Grant
- 2011-09-21 WO PCT/EP2011/066377 patent/WO2012038454A1/en active Application Filing
- 2011-09-21 BR BR112013006515A patent/BR112013006515B1/pt not_active IP Right Cessation
- 2011-09-21 CA CA2811243A patent/CA2811243C/en not_active Expired - Fee Related
-
2013
- 2013-03-14 ZA ZA2013/01950A patent/ZA201301950B/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2013118351A (ru) | 2014-10-27 |
CN103338785A (zh) | 2013-10-02 |
CA2811243C (en) | 2019-03-05 |
CN103338785B (zh) | 2015-01-14 |
EP2618841A1 (en) | 2013-07-31 |
ZA201301950B (en) | 2014-03-26 |
ES2606605T3 (es) | 2017-03-24 |
AU2011306957A1 (en) | 2013-04-11 |
WO2012038454A1 (en) | 2012-03-29 |
US20130195892A1 (en) | 2013-08-01 |
EP2618841B1 (en) | 2016-10-19 |
CA2811243A1 (en) | 2012-03-29 |
BR112013006515A2 (pt) | 2016-08-02 |
BR112013006515B1 (pt) | 2020-04-28 |
AU2011306957B2 (en) | 2014-07-24 |
AU2011306957C1 (en) | 2014-08-28 |
US9878030B2 (en) | 2018-01-30 |
RU2578943C2 (ru) | 2016-03-27 |
MX347911B (es) | 2017-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
MX342716B (es) | Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza. | |
PH12015502539A1 (en) | Cenicriviroc compositions and methods of making and using the same | |
NZ709260A (en) | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use | |
MX2013003245A (es) | Vacuna contra virus de diarrea viral de bovinos. | |
MY169159A (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
MX2018013782A (es) | Antigenos y vacunas dirigidos contra enterovirus humanos. | |
MY182771A (en) | Viral replication inhibitors | |
UA110473C2 (uk) | Спосіб лікування раку за допомогою пухлиноасоційованого антигену, отриманого із цикліну d1 | |
PH12015500713A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
PH12015502230A1 (en) | Novel viral replication inhibitors | |
PH12015501637A1 (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant | |
MX2013013801A (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
MX2013013800A (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
EA201290956A1 (ru) | Вакцина против вич | |
WO2013006569A3 (en) | Herpes virus vaccine and methods of use | |
MX350718B (es) | Vacuna de rinitis equina. | |
EA201401352A1 (ru) | Вакцина против вируса шмалленберга (sbv), способы ее получения и применения | |
EA201390452A1 (ru) | Вакцина | |
WO2013093629A3 (en) | Modular vaccines, methods and compositions related thereto | |
PH12019501907A1 (en) | Novel viral replication inhibitors | |
MX2014005499A (es) | Combinacion terapeutica de memantina y baclofeno y composicion farmaceutica que los contiene. | |
UA90646C2 (ru) | Способ лечения часто рецидивирующей хронической герпетической инфекции, вызванной вирусом герпеса простого и и ии типов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |